Skip to main navigation Skip to search Skip to main content

Hämatopoetische stammzelltransplantation und zelluläre immuntherapie

Translated title of the contribution: Hematopoietic stem cell transplantation and cellular immunotherapy
  • Joachim Kienast
  • , H. J. Kolb
  • , G. Ehninger
  • , A. D. Ho
  • Universitätsklinikum Münster
  • Ludwig-Maximilians-Universität München
  • Universitätsklinikum Carl Gustav Carus Dresden
  • Universitätsklinikum Heidelberg

Research output: Contribution to journalReview articlepeer-review

Abstract

Since initiation of the project in the year 2000, the network group has created a broad platform for collaborative trials and consensus agreements. Starting from retrospective multi-institutional surveys and proceeding via multi-center pilot and subsequent randomized trials, a structured evaluation of innovative approaches in hematopoietic stem cell transplantation and cellular immunotherapy for acute and chronic leukemias has been established in close cooperation with the disease-oriented national study groups. Successful examples of this type of vertical networking are represented by the progress that has been made in the field of optimal conditioning for allogeneic HSCT, The focus of future activities will be (i) to complete current trials, (ii) to broaden the structured evaluation activities to other indications and approaches currently at an earlier stage of clinical validation and (iii) to transfer results as standards into the health care system.

Translated title of the contributionHematopoietic stem cell transplantation and cellular immunotherapy
Original languageGerman
Pages (from-to)299-302
Number of pages4
JournalMedizinische Welt
Volume55
Issue number9
StatePublished - Sep 2004
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Hematopoietic stem cell transplantation and cellular immunotherapy'. Together they form a unique fingerprint.

Cite this